Cue Biopharma Inc buy Jefferies Financial Group Inc.
Start price
13.03.24
/
50%
€1.97
Target price
13.03.25
€5.48
Performance (%)
-23.82%
Price
31.05.24
€1.50
Summary
This prediction is currently active. The price of Cue Biopharma Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.82%. This prediction currently runs until 13.03.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cue Biopharma Inc | 0.000% | 0.000% |
iShares Core DAX® | -1.226% | 2.804% |
iShares Nasdaq 100 | -1.845% | 2.732% |
iShares Nikkei 225® | -1.132% | -2.218% |
iShares S&P 500 | -0.980% | 1.883% |
Comments by Jefferies_Financial_ for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for CUE provided by MarketBeat